Overview

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness and safety of sequential therapy with of Tri-Luma® Cream and a series of Glycolic Acid peels in treatment of moderate to severe melasma.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Fluocinolone Acetonide
Glycolic acid
Hydroquinone
Tretinoin